Lesinurad

CHEMBL2105720 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

404.3 g/mol

LogP

4.7

Phase

4

A uric acid transporter inhibitor for gout.

Masse moléculaire

404,3000 g/mol

LogP

4,70

TPSA

93,30 Å²

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Chronic Kidney Disease Gout

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

O=C(O)CSc1nnc(Br)n1-c1ccc(C2CC2)c2ccccc12

InChI

InChI=1S/C17H14BrN3O2S/c18-16-19-20-17(24-9-15(22)23)21(16)14-8-7-11(10-5-6-10)12-3-1-2-4-13(12)14/h1-4,7-8,10H,5-6,9H2,(H,22,23)

Molecular Formula

C17H14BrN3O2S

HBD / HBA

1 / 5

Liaisons Rotatives

5

Atomes Lourds

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A uric acid transporter inhibitor for gout.

Yes, Lesinurad is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2105720. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 53465279. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Lesinurad sur PillFYI

Structure

Données Clés

Formule: C17H14BrN3O2S

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.